
Notification according to Chapter 9, Section 10 of the Securities Markets Act of change in holdings in Enento Group’s shares
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE 8 NOVEMBER 2023 AT 9.00 P.M. EET
Notification according to Chapter 9, Section 10 of the Securities Markets Act of change in holdings in Enento Group’s shares
Enento Group Plc (“Enento”) has on 8 November 2023 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which the direct holding of Sampo Plc fell below the threshold of 5 percent on 8 November 2023.
The holdings of Sampo Plc in Enento amounted to 0 shares, corresponding to 0 percent of Enento’s total shares.
Enento has one share series, each share entitling to one vote. The total number of Enento’s shares is 24,034,856 shares.
Total position of Sampo Plc according to the notification:
% of shares and voting rights (total of A) | % of shares and voting rights through financial instruments (total of B) | Total of both in % (A + B) | Total number of shares and voting rights of issuer | |||||||||||
Resulting situation on the date on which threshold was crossed or reached | 0 | 0 | 0 | 24,034,856 | ||||||||||
Position of previous notification (if applicable) | 12.27 | 0 | 12.27 | |||||||||||
Notified details of the resulting situation on the date on which the thresholds were crossed: | ||||||||||||||
A: Shares and voting rights | ||||||||||||||
Class/type of shares ISIN code (if possible) | Number of shares and voting rights | % of shares and voting rights | ||||||||||||
Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |||||||||||
FI4000123195 | 0 | 0 | 0 | 0 | ||||||||||
SUBTOTAL A | 0 | 0 | ||||||||||||
B: Financial Instruments according to SMA 9:6a | ||||||||||||||
Type of financial instrument | Expiration date | Exercise/ Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights | |||||||||
Shares lent to third parties | - | - | - | - | - | |||||||||
SUBTOTAL B | - | - |
ENENTO GROUP PLC
Additional information:
Arto Paukku
Investor Relations Officer
tel. +358 50 469 5380
Distribution:
Nasdaq Helsinki Ltd
Major media
enento.com/investors
Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 399 people are working for Enento Group in Finland, Norway, Sweden, and Denmark. The Group’s net sales for 2022 was 167.5 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Biotalys Provides Company Update29.11.2023 07:00:00 CET | Press release
Review by new CEO Kevin Helash leads to focus on core capabilities and organizational changes Ghent, BELGIUM , Nov. 29, 2023 (GLOBE NEWSWIRE) -- Press release – Regulated information – Inside information (*) Progress to next-generation AGROBODY™ technology platform Update on product pipeline and regulatory review for EVOCA™(**)CSO Dr. Carlo Boutton to drive all research and early development while Dr. Eva Van Hende to head regulatory and field development; COO Luc Maertens and CBO Patrick McDonnell leaving the company Management to host a conference call and live webcast today at 15:00 CET / 14:00 GMT / 09:00 AM EST, details below Biotalys (Euronext – BTLS), today provided a company update following a strategic review of the company by CEO Kevin Helash and the board of directors. The review leads to a shift to the second-generation AGROBODY™ technology to develop protein-based biocontrols for crop and food protection. This move to AGROBODY 2.0 entails organizational changes to concentr
Nasdaq Launches New Technology to Scale Global Carbon Markets29.11.2023 07:00:00 CET | Press release
Technology Securely Digitizes the Issuance, Settlement, and Custody of Carbon Credits Service Uses Smart Contract Language, Deployed via Private Centralized Database or Private, Blockchain Technology for Enterprises Puro.earth to Register Carbon Removal Credits Using the Technology NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the launch of a pioneering new technology that securely digitizes the issuance, settlement, and custody of carbon credits. It will be provided to market infrastructures, registry platforms, and other service providers globally. The service will ultimately support the development and institutionalization of global carbon markets. Despite being a relatively young market the carbon credit operating model is characterized by bilateral trading and a heavy reliance on manual interaction, providing limited ability to scale as the market develops. This inflexibility has also led to an absence of standardization – where credit data can
Hydros kapitalmarkedsdag 2023: En pioner i det grønne aluminiumskiftet med kraft fra fornybar energi29.11.2023 07:00:00 CET | Pressemelding
Hydro øker satsingen på å utnytte mulighetene som oppstår gjennom økt etterspørsel etter lavkarbonaluminium. Fram mot 2030 vil Hydro øke veksten i resirkulering av aluminium og ekstruderte produkter, og styrke ambisjonene innen produksjon av fornybar energi. Hydro vil gjennomføre planlagt avkarbonisering og bidra til en omstilling som er rettferdig og naturpositiv, samtidig som markedet for grønnere aluminium videreutvikles. Dette er hovedtemaene på Hydros kapitalmarkedsdag 2023. Hovedpunkter Forventer en økning på opptil 2 milliarder kroner i grønnere inntjening innen 2030Trapper opp veksten i Extrusions til en EBITDA på 10-12 milliarder kroner i 2030Trapper opp veksten i resirkulering til en EBITDA på 5-8 milliarder kroner i 2030, delvis gjennom å øke mengden brukt aluminiumskrap til 850.000-1.200.000 tonn innen 2030Øker målet for utslippskutt for CO2 fram mot 2030, der målet om 30 prosent reduksjon opprettholdes til tross for porteføljeendringer, og trapper opp naturpositive tiltak
Hydro Capital Markets Day 2023: Pioneering the green aluminium transition, powered by renewable energy29.11.2023 07:00:00 CET | Press release
Hydro is shifting gear to capture opportunities created by increased demand for low-carbon aluminium. Towards 2030, Hydro will step up growth in aluminium recycling and extrusions, and in its ambitions within renewable power generation. Hydro will execute on its decarbonization roadmap, and contribute to nature positive and a just transition, while shaping the market for greener aluminium. These are key topics for Hydro’s Capital Markets Day 2023. Key highlights Expecting up to NOK 2 billion greener earnings uplift by 2030Stepping up growth in Extrusions to NOK 10-12 billion EBITDA in 2030Stepping up growth in Recycling to NOK 5-8 billion EBITDA in 2030, partially driven by increasing post-consumer scrap to 850-1,200 kt by 2030Increasing CO2 reduction target until 2030, maintaining 30% target despite portfolio changes, and stepping up nature positive efforts through initiatives on biodiversity, waste handling and land useIncreasing improvement program to NOK 14 billion in 2030, includi
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure29.11.2023 07:00:00 CET | Press release
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 29 November 2023, 07:00 am CET Data from all three patients in non-randomized cohort treated with DSR 2.0 indicate safe and effective maintenance of euvolemia without the need for loop diuretics,considerable benefit in cardiorenal status and dramatic improvement in diuretic response and loop diuretic requirements up to 11 weeks post DSR treatment DSMBi review planned for early Q1 2024 to approve start of randomized controlled cohort of up to 30 US patients Ghent, Belgium – 29 November 2023– Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that all three patients from the non-randomized cohort of the MOJAVE study were successfully treated with DSR 2.0. Data from the third patient show similar beneficial effects of DSR therapy as reported previously in the first two patientsii. Dr. Oliver Gödje,